These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2224434)

  • 1. Prostatic carcinoma: histological and immunohistological factors affecting prognosis.
    Cohen RJ; Glezerson G; Haffejee Z; Afrika D
    Br J Urol; 1990 Oct; 66(4):405-10. PubMed ID: 2224434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolar organizer regions (NOR) in hyperplastic and neoplastic prostate disease.
    Deschênes J; Weidner N
    Am J Surg Pathol; 1990 Dec; 14(12):1148-55. PubMed ID: 2252105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleolar organiser regions in hyperplastic and neoplastic prostatic tissue.
    Hansen AB; Ostergård B
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(1):9-13. PubMed ID: 1694333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleolar organizer regions in benign and malignant prostatic disease.
    Lloyd SN; Johnson CP; Brown IL; Kirk D
    Histopathology; 1991 May; 18(5):449-52. PubMed ID: 1715842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AgNOR staining in benign hyperplasia and carcinoma of the prostate.
    Mamaeva S; Lundgren R; Elfving P; Limon J; Mandahl N; Mamaev N; Henrikson H; Heim S; Mitelman F
    Prostate; 1991; 18(2):155-62. PubMed ID: 1706512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuro-endocrine cells--a new prognostic parameter in prostate cancer.
    Cohen RJ; Glezerson G; Haffejee Z
    Br J Urol; 1991 Sep; 68(3):258-62. PubMed ID: 1913066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silver staining nucleolar organizer region in prostate cytology.
    Bittinger A; von Keitz A; Rüschoff J; Melekos MD
    Zentralbl Pathol; 1994 Mar; 140(1):103-6. PubMed ID: 7515666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
    Helpap B; Riede C
    Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argyrophilic nucleolar organizer regions in atypical adenomatous hyperplasias, prostatic intraepithelial neoplasias and prostatic neoplasms.
    Mukherjee J; Misra V; Gupta SC; Gupta AK; Tandon SP
    Urol Int; 1997; 58(2):75-9. PubMed ID: 9096266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleolar organizer regions in low- and high-grade carcinomas of the prostate.
    Helpap B; Riede C
    World J Urol; 1995; 13(3):195-9. PubMed ID: 7550395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between the nucleolar organizer region in adenocarcinoma of the prostate and the Gleason system].
    Sentinelli S; Pizzuti V; Rondanelli E; Viggiani F; Paolini R
    Pathologica; 1992; 84(1089):49-55. PubMed ID: 1379709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silver-stained nucleolar organizer regions in the differentiation of prostatic hyperplasia, intraepithelial neoplasia, and adenocarcinoma.
    Cheville JC; Clamon GH; Robinson RA
    Mod Pathol; 1990 Sep; 3(5):596-8. PubMed ID: 1700418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolar organiser regions (AgNORs) related to histopathological characteristics and survival in prostatic adenocarcinoma.
    Eskelinen M; Lipponen P; Syrjänen K
    Anticancer Res; 1992; 12(5):1635-40. PubMed ID: 1444230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High and low risk prostate carcinoma determined by histologic grade and proliferative activity.
    Chiusa L; Galliano D; Formiconi A; Di Primio O; Pich A
    Cancer; 1997 May; 79(10):1956-63. PubMed ID: 9149023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silver-binding nucleolar organizer regions in benign and malignant prostatic lesions.
    Pavlakis K; Alivizatos G; Mitropoulos D; Constantinides C; Skopelitou A; Kittas C; Dimopoulos C
    Urol Int; 1992; 49(3):137-40. PubMed ID: 1281586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker".
    Abrahamsson PA; Falkmer S; Fält K; Grimelius L
    Pathol Res Pract; 1989 Sep; 185(3):373-80. PubMed ID: 2813190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [AGNOR analyses of prostate carcinomas of high and malignancy].
    Helpap B; Riede C
    Verh Dtsch Ges Pathol; 1993; 77():93-7. PubMed ID: 7511310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silver-stained structures in prostatic carcinoma: evaluation of diagnostic and prognostic relevance by automated image analysis.
    Contractor H; Rüschoff J; Hanisch T; Ulshöfer B; Neumann K; Schultze-Seemann W; Thomas C
    Urol Int; 1991; 46(1):9-14. PubMed ID: 1708924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleolar organiser regions (NORs) in bladder cancer; relation to histological grade, clinical stage and prognosis.
    Lipponen PK; Eskelinen MJ
    Anticancer Res; 1991; 11(1):75-80. PubMed ID: 2018387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.